Showing results (221-230 of 351) with videos related to
Sort By:
Pageof 36
International Journal of Cancer|September 13, 2016
Longitudinal fluctuation in mammographic percent density differentiates between interval and screen-detected breast cancerFredrik Strand, Keith Humphreys, Mikael Eriksson, et al.Science Translational Medicine|January 28, 2021
Toward robust mammography-based models for breast cancer riskAdam Yala, Peter G Mikhael, Fredrik Strand, et al.Molecular Oncology|June 19, 2021
Integrated multi-omics profiling of high-grade estrogen receptor-positive, HER2-negative breast cancerKang Wang, Lun Li, Sebastià Franch-Expósito, et al.Breast Cancer Research and Treatment|December 1, 2017
Long-term safety and survival outcomes from the Scandinavian Breast Group 2004-1 randomized phase II trial of tailored dose-dense adjuvant chemotherapy for early breast cancerAlexios Matikas, Sara Margolin, Mats Hellström, et al.Radiology|September 8, 2020
Identification of Women at High Risk of Breast Cancer Who Need Supplemental ScreeningMikael Eriksson, Kamila Czene, Fredrik Strand, et al.Cancer|December 19, 2019
Efficacy and safety of tailored and dose-dense adjuvant chemotherapy and trastuzumab for resected HER2-positive breast cancer: Results from the phase 3 PANTHER trialAntroula Papakonstantinou, Alexios Matikas, Nils Olof Bengtsson, et al.Nature Biotechnology|January 5, 2023
Solid-phase capture and profiling of open chromatin by spatial ATACEnric Llorens-Bobadilla, Margherita Zamboni, Maja Marklund, et al.Cancer Research|August 3, 2021
Predicting Molecular Phenotypes from Histopathology Images: A Transcriptome-Wide Expression-Morphology Analysis in Breast CancerYinxi Wang, Kimmo Kartasalo, Philippe Weitz, et al.Medical Physics|January 31, 2019
Derived mammographic masking measures based on simulated lesions predict the risk of interval cancer after controlling for known risk factors: a case-case analysisBenjamin Hinton, Lin Ma, Amir Pasha Mahmoudzadeh, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 2024
Tailored Dose-Dense Versus Standard Adjuvant Chemotherapy for High-Risk Early Breast Cancer: End-of-Study Results of the Randomized PANTHER TrialAlexios Matikas, Volker Möbus, Richard Greil, et al.Pageof 36